Button: Reserve Fluzone vaccine at VaccineShoppe.com

Coding and Reimbursement Guidelines

Comprehensive information for adherence to federal regulations

Fluzone® (Influenza Vaccine) Portfolio Age Group When the Payer Requires the Outer Carton NDCa When the Payer Requires the Unit-Of-Use NDC (Vial or Syringe) Presentation and Dose Vaccine Code Administration Code ICD-10b Code
Fluzone Quadrivalent Vaccine, No Preservative: Pediatric Dose 6 - 35 months of age N449281051725 ML0.25 N449281051700 ML0.25 0.25-mL single-dose syringe 90685 When qualified counselling occurs 90460. If qualified counselling does not occur 90471 or 90472. Medicare patients use G0008 Z23
CPT®c 90685 = Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use
Fluzone Quadrivalent Vaccine, No Preservative 3 years of age and older N449281041750 ML0.5 N449281041788 ML0.5 0.5-mL single-dose syringe 90686 When the patient is 18 years of age and younger and qualified counselling occurs 90460. If qualified counselling does not occur or when the patient is 19 years of age and older 90471 or 90472. Medicare patients use G0008 Z23
N449281041710 ML0.5 N449281041758 ML0.5 0.5-mL single-dose vial
CPT 90686 = Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use
Fluzone Quadrivalent Vaccine 6 months of age and older N449281062715 ML0.25 N449281062778 ML0.25 5-mL multidose vial   When the patient is 18 years of age and younger and qualified counselling occurs 90460. If qualified counselling does not occur or when the patient is 19 years of age and older 90471 or 90472. Medicare patients use G0008 Z23
0.25-mL dose taken from 5-mL multidose vial 90687
N449281062715 ML0.5 N449281062778 ML0.5 0.5-mL dose taken from 5-mL multidose vial 90688
CPT 90687 = Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use
CPT 90688 = Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use
Fluzone High-Dose Vaccine, No Preservative 65 years of age and older N449281040165 ML0.5 N449281040188 ML0.5 0.5-mL single-dose syringe 90662 Medicare patients use G0008. Commercial patients can use 90471 or 90472 Z23
CPT 90662 = Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use
Fluzone Intradermal Quadrivalent Vaccine, No Preservative 18 - 64 years of age N449281071240 ML0.1 N449281071248 ML0.1 0.1-mL single-dose microinjection system 90630 Medicare patients use G0008. Commercial patients can use 90471 or 90472 or when the patient is 18 years of age and qualified counselling occurs 90460 Z23
CPT 90630 = Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intramuscular use
a NDC = National Drug Code; b ICD-10 = International Classification of Diseases-10th Modification; c CPT (Current Procedural Terminology) is a registered trademark of the American Medical Association.

MKT31793      3/17

Do you have questions on coverage or payment for Sanofi Pasteur products? Contact the Sanofi Pasteur Reimbursement Support Service (RSS). Call 1-800-VACCINE (1-800-822-2463) 1-800-VACCINE (1-800-822-2463) and choose the prompt for the RSS.

Chart: Coding and Reimbursement Guidelines: Comprehensive information for adherence to federal regulations

PLEASE NOTE

By clicking on this link, you will be leaving this Sanofi Pasteur website and going to another, entirely independent website. Sanofi Pasteur provides this link as a service to its website visitors; however, it takes no responsibility for the information presented on any website but its own.

This link has opened in a new window. To return to your original site, please close this new window.

Click here to go to the page you requested. Click here to close this window and return to the site.

PLEASE NOTE

By clicking on this link, you will be leaving this Sanofi Pasteur website and going to another Sanofi Pasteur website.

This link has opened in a new window. To return to your original site, please close this new window.

Click here to go to the page you requested. Click here to close this window and return to the site.